Epirubicin

Generic name: Epirubicin
Dosage form: intravenous solution (2 mg/mL)
Drug class: Antibiotics / antineoplastics

Usage of Epirubicin

Epirubicin is used to treat breast cancer.

Epirubicin may also be used for purposes not listed in this medication guide.

Epirubicin side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Epirubicin can cause dangerous effects on your heart that may not be reversible and could occur months to years after you receive epirubicin. Call your doctor right away if you have symptoms of heart problems: swelling, rapid weight gain, shortness of breath.

Also call your doctor at once if you have:

fast or slow heartbeats;

easy bruising, unusual bleeding, purple or red spots under your skin;

unusual tiredness, feeling light-headed or short of breath, cold hands and feet;

pain, blistering, redness, bruising, or skin changes where the injection was given;

severe vomiting;

dehydration symptoms--feeling very thirsty or hot, being unable to urinate, heavy sweating, or hot and dry skin;

fluid build-up in or around the lungs--pain when you breathe, feeling short of breath while lying down, wheezing, gasping for breath, cough with foamy mucus, cold and clammy skin, anxiety, rapid heartbeats;

signs of tumor cell breakdown--tiredness, weakness, muscle cramps, nausea, vomiting, diarrhea, fast or slow heart rate, tingling in your hands and feet or around your mouth; or

signs of infection--fever, chills, flu symptoms, mouth sores, shallow breathing, pale or blue-colored skin.

Common side effects of epirubicin may include:

nausea, vomiting, diarrhea;

temporary hair loss;

blisters or ulcers in your mouth, red or swollen gums, trouble swallowing;

hot flashes, missed menstrual periods;

discoloration of your skin or nails;

lack of energy; or

red-colored urine for 1 or 2 days after each injection.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Epirubicin

Before you are treated with epirubicin, tell your doctor about all other cancer medications and treatments you have received, including radiation.

You should not use this medication if you are allergic to epirubicin or similar medications (such as daunorubicin, doxorubicin, idarubicin,mitoxantrone, or valrubicin), or if you have:

an untreated or uncontrolled infection (including mouth sores);

severe liver disease;

severe heart problems; or

if you have recently had a heart attack.

You may not be able to use epirubicin if you have already been treated with a certain amount of other cancer medications.

Tell your doctor if you have ever had:

heart problems;

radiation to your chest area;

liver or kidney disease;

bone marrow suppression; or

chemotherapy with doxorubicin, daunorubicin, epirubicin, idarubicin, or mitoxantrone.

Using epirubicin may increase your risk of developing other cancers, such as leukemia. Ask your doctor about this risk.

Both men and women using this medicine should use effective birth control to prevent pregnancy. Epirubicin can harm an unborn baby if the mother or father is using this medicine.

Epirubicin may cause you to stop having menstrual periods and may also cause premature menopause. Talk with your doctor if you have concerns about these risks.

You should not breastfeed while using epirubicin.

Relate drugs

How to use Epirubicin

Usual Adult Dose for Breast Cancer -- Adjuvant:

Initial dose: 100 to 120 mg/m2 IV in repeated 3- to 4-week cycles; either total dose on Day 1 of each cycle, or divided equally and given on Days 1 and 8 of each cycleCEF-120 regimen (repeat every 28 days for 6 cycles):-Cyclophosphamide: 75 mg/m2 orally on Days 1 to 14-Epirubicin: 60 mg/m2 IV on Days 1 and 8-5-Fluorouracil: 500 mg/m2 IV on Days 1 and 8FEC-100 regimen (repeat every 21 days for 6 cycles):-5-Fluorouracil: 500 mg/m2 IV on Day 1 -Epirubicin: 100 mg/m2 IV on Day 1-Cyclophosphamide: 500 mg/m2 IV on Day 1Recommended infusion rates:-For starting doses of 100 to 120 mg/m2, give the infusion over 15 to 20 minutes.-For patients who require lower starting doses due to organ dysfunction or who require modification of doses during therapy, the infusion time may be proportionally decreased, but should not be less than 3 minutes to minimize the risk of thrombosis or perivenous extravasation, which could lead to severe cellulitis, vesication, or tissue necrosis.-A direct push injection is not recommended due to the risk of extravasation, which may occur even in the presence of adequate blood return upon needle aspiration. Venous sclerosis may result from injection into small vessels or repeated injections into the same vein.Comments:-Doses are manufacturer suggested. Consult local protocol.-Consider use of antiemetics when given in conjunction with other emetogenic drugs.-Patients administered the 120 mg/m2 regimen should receive prophylactic antibiotics.Use: As adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer

Warnings

You should not use epirubicin if you have an untreated or uncontrolled infection, severe liver disease, severe heart problems, or if you have recently had a heart attack. You may not be able to use epirubicin if you have already been treated with a certain amount of other cancer medications.

Tell your caregivers if you feel any burning, pain, or swelling around the needle when epirubicin is injected.

Epirubicin affects your immune system. You may get infections more easily, even serious or fatal infections. You will need frequent medical tests and your cancer treatments may be delayed.

What other drugs will affect Epirubicin

Tell your doctor about all your other medicines, especially:

cimetidine (Tagamet);

other cancer medicines; or

heart or blood pressure medication.

This list is not complete. Other drugs may affect epirubicin, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.